TAK1-IN-5
TAK1-IN-5 (Compound 26) is an inhibitor of the transforming growth factor-β activated kinase (TAK1) with an IC50 value of 55 nM. TAK1-IN-5 can inhibit the growth of MPC-11 and H929 cells with a GI50 lower than 30 nM. TAK1-IN-5 can be used in the study of multiple myeloma [1].
Product Specifications
UNSPSC
12352005
Target
MAP3K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tak1-in-5.html
Solubility
10 mM in DMSO
Smiles
CC1CN(CC(O1)C)C2=NN3C(C4=CC5=C(NN=C5C6CC6)C=C4)=CN=C3C=C2
Molecular Formula
C22H24N6O
Molecular Weight
388.47
References & Citations
[1]Akwata D, et al. Discovery of imidazo[1,2-b]pyridazine-containing TAK1 kinase inhibitors with excellent activities against multiple myeloma. RSC Med Chem. 2023 Nov 28;15 (1) :178-192.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Pax5/BSAP Antibody (rPAX5/4228) [Allophycocyanin]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-08419APC 0.1 mL
Mouse Monoclonal Pax5/BSAP Antibody (rPAX5/4228) [Allophycocyanin]
Ask
View Details MBS6206950-01 0.1 mL
IPF1 (Pancreatic and duodenal Homeobox 1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1) (MaxLight 490)
Ask
View Details MBS6206950-02 5x 0.1 mL
IPF1 (Pancreatic and duodenal Homeobox 1, GSF, IDX-1, IPF1, IUF1, MODY4, PDX-1, STF-1) (MaxLight 490)
Ask
View Details MBS1007371-01 0.02 mg (E-Coli)
Recombinant Bacillus subtilis Uncharacterized protein yqaC (yqaC)
Ask
View Details 
MBS1007371-02 0.1 mg (E-Coli)
Recombinant Bacillus subtilis Uncharacterized protein yqaC (yqaC)
Ask
View Details 
MBS1007371-03 0.02 mg (Yeast)
Recombinant Bacillus subtilis Uncharacterized protein yqaC (yqaC)
Ask
View Details